arrow
G

Glenn M. Chertow

stanford university school of medicine
H指数:151
被引数:10.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cardiovascular Trials in Hemodialysis

血液透析中的心血管试验

JACC
IF0
2026-04-210
PRE
Effect of Clazakizumab on Neutrophil-Lymphocyte Ratio in Patients Receiving Hemodialysis: Secondary Analysis of the POSIBIL6ESKD Phase 2b Trial

Clazakizumab对接受血液透析患者中性粒细胞-淋巴细胞比值的影响:POSIBIL6ESKD 2b期试验的二次分析

2026-02-010
PRE
Safety and Efficacy of Vadadustat Versus Darbepoetin Alfa for Chronic Kidney Disease-Related Anemia in Patients Receiving Dialysis by Baseline Erythropoiesis-Stimulating Agent Dose

维达环素(vadadustat)与达贝泊汀α(darbepoetin alfa)治疗接受透析的慢性肾病相关贫血的疗效与安全性:基于基线促红细胞生成剂剂量的比较研究

2025-12-010
OAAI
Risk factors for mortality in patients with kidney failure on hemodialysis identified by proteomic analysis of CRIC and PACE studies

通过CRIC和PACE研究蛋白质组学分析确定的血液透析肾衰竭患者的死亡风险因素

2025-11-270
OAAI
The Association of Serum Bicarbonate with Psychological and Physical Health-Related Quality of Life in Patients Receiving Maintenance Hemodialysis: A Secondary Analysis of the Frequent Hemodialysis Network (FHN) Daily Trial

血清碳酸氢盐与接受维持性血液透析患者心理和躯体健康相关生活质量的关系:Frequent Hemodialysis Network (FHN) Daily Trial的二次分析

2025-09-030
PRE